Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
MasterCard
MA
5
American Express
AXP
JP Stock MarketDetailed Quotes
197A Tauns Laboratories
- 502
- -3-0.59%
20min DelayMarket Closed May 2 15:30 JST
51.40BMarket Cap9.30P/E (Static)
510High500Low413.10KVolume508Open505Pre Close208.22MTurnover73352wk High1.78%Turnover Ratio102.39MShares40152wk Low53.99EPS TTM11.67BFloat Cap733Historical High9.30P/E (Static)23.25MShs Float401Historical Low53.99EPS LYR1.98%Amplitude11.00Dividend TTM3.15P/B100Lot Size2.12%Div YieldTTM
Tauns Laboratories News
Tauns Laboratories: TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with Craif Inc., a Startup Developing Urinary MicroRNA-Based Tests fo
Tauns Laboratories: Towns Co., Ltd. signed a capital and business partnership agreement with CraiF Co., Ltd., a startup that performs early cancer detection tests using urinary microRNA
Tauns Laboratories: Notice of Capital and Business Alliance with Aillis, Inc. and Acquisition of Shares through Third-Party Allocation of New Shares.
Tauns Laboratories: Notice regarding capital and business alliance with Iris Co., Ltd. and acquisition of the company's shares through third-party allotment of shares
Tauns Laboratories: TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with KINS Co., Ltd., a Healthcare Startup Specializing in Microbiomes
Tauns Laboratories: A capital and business alliance agreement was concluded with KINS Co., Ltd., a healthcare startup specializing in Towns Microbiome Co., Ltd.
Tauns Laboratories: Financial Highlights for 2Q ended December 31, 2024
Tauns Laboratories: Financial Results for the SIX Months Ended December 31, 2024 (Japanese Accounting Standards)
Tauns Laboratories: Notice of Strategic Business Alliance with ZACROS Corporation
Tauns Laboratories: Announcement of a strategic business alliance with ZACROS Co., Ltd.
Tauns Laboratories: Patent on Method and Reagent for Detecting Target Substance Granted in Japan
Tauns Laboratories: Notice of patent acquisition relating to target substance detection methods and reagents
Tauns Laboratories: (Update on Disclosed Matters) Notice of Entry into Master Transaction Agreement with Roche Diagnostics K.K.
Tauns Laboratories: (Progress of disclosure matters) Notice of conclusion of a basic transaction agreement with Roche Diagnostics Co., Ltd.
Tauns Laboratories: Notice concerning Memorandum of Understanding to enter into Master Transaction Agreement between TAUNS Laboratories, Inc. and Roche Diagnostics K.K.
Tauns Laboratories: Notice of conclusion of a basic agreement on the basic transaction agreement between Towns and Roche Diagnostics
Tauns Laboratories: Notice regarding Preparation for Application for Change of Market Classification to the Prime Market of the Tokyo Stock Exchange
Tauns Laboratories: Notice regarding preparations for applying for a change in market classification to the Tokyo Stock Exchange Prime Market
Tauns Laboratories: Supplementary Material on Financial Results for the Three Months Ended September 30, 2024
Tauns Laboratories: Financial Results for the Three Months Ended September 30, 2024 (Japanese Accounting Standards)
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting